D. Borden Lacy

11.6k citations

197 papers · 8.6k indexed · 2 hit papers · h-index 51

Molecular Biology top 2%
Infectious Diseases top 0.5%
Genetics top 1%
Surgery top 2%
Immunology top 2%

Co-authors: R. John Collier David H. Wasserman Raymond C. Stevens Ramyavardhanee Chandrasekaran Phillip E. Williams Alan D. Cherrington Dena Lyras Rory N. Pruitt
Topics: Clostridium difficile and Clostridium perfringens research (52 papers)Diet and metabolism studies (35 papers)Muscle metabolism and nutrition (29 papers)
Cited by: Infectious Diseases Immunology Neurology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States Canada United Kingdom

In The Last Decade

D. Borden Lacy

190 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clostridium difficile infection

2016 599 citations Dena Lyras, D. Borden Lacy et al. profile →
Crystal structure of botulinum neurotoxin type A and implications for toxicity

1998 569 citations D. Borden Lacy et al. profile →

Peers

Countries citing papers authored by D. Borden Lacy

Since Specialization

Citations

This map shows the geographic impact of D. Borden Lacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Borden Lacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Borden Lacy more than expected).

Fields of papers citing papers by D. Borden Lacy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Borden Lacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Borden Lacy. The network helps show where D. Borden Lacy may publish in the future.

Co-authorship network of co-authors of D. Borden Lacy

This figure shows the co-authorship network connecting the top 25 collaborators of D. Borden Lacy. A scholar is included among the top collaborators of D. Borden Lacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Borden Lacy. D. Borden Lacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Species-specific components of the Helicobacter pylori Cag type IV secretion system 2025 ·Infection and Immunity ·(unknown),Arwen E. Frick-Cheng,(unknown),Heather K. Kroh,W. Hayes McDonald,D. Borden Lacy,Mark S. McClain,Melanie D. Ohi,Timothy L. Cover	0
2	Sa1228 DELETED IN MALIGNANT BRAIN TUMORS 1 (DMBT1) GLYCOPROTEIN IS LOST IN EARLY COLONIC DYSPLASIA 2023 ·Gastroenterology ·(unknown),(unknown),Megan J. Rutherford,John A. Shupe,Robert J. Coffey,D. Borden Lacy,Nicholas O. Markham	0
3	Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo 2023 ·PLoS Pathogens ·Shannon L. Kordus,Heather K. Kroh,(unknown),(unknown),(unknown),John A. Shupe,Brian E. Wadzinski,D. Borden Lacy,Benjamin W. Spiller	10
4	Strain Variation in Clostridioides difficile Cytotoxicity Associated with Genomic Variation at Both Pathogenic and Nonpathogenic Loci 2022 ·mSphere ·(unknown),Ali Pirani,D. Borden Lacy,Philip C. Hanna,Evan S. Snitkin	6
5	Molecular architecture of bacterial type IV secretion systems 2022 ·PLoS Pathogens ·Michael J. Sheedlo,Melanie D. Ohi,D. Borden Lacy,Timothy L. Cover	46
6	Persistent bacteremia and psoas abscess caused by a lethal toxin-deficient Paeniclostridium sordellii 2022 ·Anaerobe ·Cara D Varley,Lisa M. Rogers,Beverly R. E. A. Dixon,(unknown),D. Borden Lacy,(unknown),David M. Aronoff,John M. Townes	1
7	Paeniclostridium sordellii uterine infection is dependent on the estrous cycle 2022 ·PLoS Pathogens ·(unknown),M. Kay Washington,D. Borden Lacy	3
8	Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection 2022 ·PLoS Pathogens ·(unknown),John A. Shupe,(unknown),Kevin O. Childress,M. Kay Washington,Sarah A. Kuehne,D. Borden Lacy	17
9	Murine Intrarectal Instillation of Purified Recombinant Clostridioides difficile Toxins Enables Mechanistic Studies of Pathogenesis 2021 ·Infection and Immunity ·Nicholas O. Markham,(unknown),John A. Shupe,(unknown),(unknown),Heather K. Kroh,Kevin O. Childress,(unknown),M. Kay Washington,Robert J. Coffey,D. Borden Lacy	12
10	Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics 2021 ·Nature Reviews Microbiology ·Shannon L. Kordus,(unknown),D. Borden Lacy	102
11	Intestinal bile acids directly modulate the structure and function of C. difficile TcdB toxin 2020 ·Proceedings of the National Academy of Sciences ·John Tam,(unknown),(unknown),(unknown),Rodolfo F. Gómez‐Biagi,Casey M. Theriot,Heather K. Kroh,Stacey A. Rutherford,D. Borden Lacy,Roman A. Melnyk	57
12	Clostridioides difficile infection damages colonic stem cells via TcdB, impairing epithelial repair and recovery from disease 2020 ·Proceedings of the National Academy of Sciences ·Steven J. Mileto,Thierry Jardé,Kevin O. Childress,(unknown),(unknown),Genevieve Kerr,M. Hutton,Michael J. Sheedlo,(unknown),John A. Shupe,Katja Horvay,(unknown),Rebekah Engel,Simon Wilkins,Paul J. McMurrick,D. Borden Lacy,Helen E. Abud,Dena Lyras	75
13	Cryo-EM reveals species-specific components within the Helicobacter pylori Cag type IV secretion system core complex 2020 ·eLife ·Michael J. Sheedlo,Jeong Min Chung,(unknown),(unknown),Timothy L. Cover,Melanie D. Ohi,D. Borden Lacy	39
14	Structure of the Helicobacter pylori Cag type IV secretion system 2019 ·eLife ·Jeong Min Chung,Michael J. Sheedlo,A. Malcolm Campbell,(unknown),Arwen E. Frick-Cheng,D. Borden Lacy,Timothy L. Cover,Melanie D. Ohi	73
15	Antibacterial photosensitization through activation of coproporphyrinogen oxidase 2017 ·Proceedings of the National Academy of Sciences ·(unknown),Dennis J. Horvath,(unknown),(unknown),(unknown),(unknown),Kenneth J. Salleng,(unknown),(unknown),Nagarajan Raju,Pedro L. Teixeira,Matthew E. Albertolle,Ivelin S. Georgiev,E. Jansen,Gary A. Sulikowski,D. Borden Lacy,Harry A. Dailey,Eric P. Skaar	16
16	A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain 2016 ·Infection and Immunity ·Christian González‐Rivera,A. Malcolm Campbell,Stacey A. Rutherford,(unknown),Nora J. Foegeding,(unknown),Benjamin W. Spiller,Mark S. McClain,Melanie D. Ohi,D. Borden Lacy,Timothy L. Cover	19
17	Structural organization of the functional domains of Clostridium difficile toxins A and B 2010 ·Proceedings of the National Academy of Sciences ·Rory N. Pruitt,Melissa G. Chambers,Kenneth Ng,Melanie D. Ohi,D. Borden Lacy	117
18	Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain 2007 ·Proceedings of the National Academy of Sciences ·(unknown),(unknown),Devin L. Stauff,Ben Spiller,Mark S. McClain,Timothy L. Cover,D. Borden Lacy	126
19	Disposition of a Mixed Meal by Conscious Dogs after Seven Days of Treatment with Cyclosporine A and Prednisone 2000 ·Journal of Parenteral and Enteral Nutrition ·Mary Courtney Moore,Alan D. Cherrington,(unknown),D. Borden Lacy,Richard E. Goldstein	3
20	The effects of acute elevations in plasma cortisol levels on alanine metabolism in the conscious dog 1992 ·Metabolism ·Richard E. Goldstein,George Reed,David H. Wasserman,Phillip E. Williams,D. Borden Lacy,(unknown),Naji N. Abumrad,Alan D. Cherrington	25

About D. Borden Lacy

D. Borden Lacy is a scholar working on Infectious Diseases, Endocrinology, Diabetes and Metabolism and Physiology, having authored 197 papers that have together received 8.6k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (52 papers), Diet and metabolism studies (35 papers) and Muscle metabolism and nutrition (29 papers). The work is most often cited by research in Infectious Diseases (2.6k citations), Immunology (1.4k citations) and Neurology (970 citations). D. Borden Lacy has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include R. John Collier, David H. Wasserman, Raymond C. Stevens, Ramyavardhanee Chandrasekaran, Phillip E. Williams, Alan D. Cherrington, Dena Lyras, Rory N. Pruitt, Wiep Klaas Smits and Mark H. Wilcox. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact